USANA Health Sciences, Inc.
NYSE:USNA
30.93 (USD) • At close September 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue
| 854.503 | 921.01 | 998.601 | 1,186.464 | 1,134.644 |
| Cost of Revenue
| 161.212 | 176.693 | 193.89 | 217.898 | 209.111 |
| Gross Profit
| 693.291 | 744.317 | 804.711 | 968.566 | 925.533 |
| Gross Profit Ratio
| 0.811 | 0.808 | 0.806 | 0.816 | 0.816 |
| Reseach & Development Expenses
| 0 | 11.446 | 11.563 | 11.112 | 10.633 |
| General & Administrative Expenses
| 263.268 | 256.989 | 262.304 | 279.107 | 261.186 |
| Selling & Marketing Expenses
| 368.666 | 394.257 | 434.793 | 519.267 | 487.856 |
| SG&A
| 263.268 | 651.246 | 697.097 | 798.374 | 749.042 |
| Other Expenses
| 363.699 | -11.446 | -11.563 | -11.112 | -10.633 |
| Operating Expenses
| 626.967 | 651.246 | 697.097 | 798.374 | 749.042 |
| Operating Income
| 66.324 | 93.071 | 107.614 | 170.192 | 176.491 |
| Operating Income Ratio
| 0.078 | 0.101 | 0.108 | 0.143 | 0.156 |
| Total Other Income Expenses Net
| 10.027 | 9.382 | 1.007 | 0.45 | 1.457 |
| Income Before Tax
| 76.351 | 102.453 | 108.621 | 170.642 | 177.948 |
| Income Before Tax Ratio
| 0.089 | 0.111 | 0.109 | 0.144 | 0.157 |
| Income Tax Expense
| 34.291 | 38.665 | 39.271 | 54.137 | 53.284 |
| Net Income
| 42.03 | 63.788 | 69.35 | 116.505 | 124.664 |
| Net Income Ratio
| 0.049 | 0.069 | 0.069 | 0.098 | 0.11 |
| EPS
| 2.2 | 3.33 | 3.6 | 5.78 | 5.89 |
| EPS Diluted
| 2.19 | 3.3 | 3.59 | 5.73 | 5.86 |
| EBITDA
| 98.861 | 123.11 | 130.223 | 192.892 | 200.964 |
| EBITDA Ratio
| 0.116 | 0.134 | 0.13 | 0.163 | 0.177 |